<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Horizon Pharma, Inc. Announces Results Of Phase 3 Study Of LODOTRA® Demonstrate 12-Month Sustained E&#8230;</title>
	<atom:link href="http://shallaki.net/horizon-pharma-inc-announces-results-of-phase-3-study-of-lodotra-demonstrate-12-month-sustained-e/feed/" rel="self" type="application/rss+xml" />
	<link>http://shallaki.net/horizon-pharma-inc-announces-results-of-phase-3-study-of-lodotra-demonstrate-12-month-sustained-e/</link>
	<description>shallaki online</description>
	<pubDate>Tue, 22 May 2012 00:12:36 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
	</channel>
</rss>

